MarketCap
Facebook
X
Telegram
McKesson Corporation Balance Sheet 2026-2007 | MCK
Brief overview of McKesson Corporation's balance sheet structure
This overview follows the five latest available annual observations between 2016 and 2020.
The asset base gained +8.3%, from $56.6 billion to $61.2 billion; average annual growth of 2% remained moderate.
Liability growth of +17.6% exceeded asset growth of +8.3%, increasing reliance on outside funding.
Internal capital represents 8.3% of the balance sheet versus 15.8% five periods ago. The cushion is thin.
The net-debt-to-equity ratio is 0.66x. Borrowed funding is already a meaningful part of the structure.
Cash accounts for 6.6% of assets versus 7.2% initially. The change indicates the degree of financial flexibility.
Retained earnings are $13 billion versus $8.4 billion initially. The direction shows how results contributed to equity.
Conclusion
McKesson Corporation's balance sheet profile remains vulnerable. Lower liabilities and capital accumulation are the main routes to improvement.
Annual Balance Sheet McKesson Corporation
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.84 B | 221 M | 1.34 B | 1.22 B | 2.64 B | 1.26 B | 3.37 B | 4.61 B | 5.21 B | 5.58 B | 4.11 B | 4.5 B | 6.53 B | 2.42 B | 831 M | 392 M | -1.44 B | 181 M | - | - |
Long Term Debt |
6.53 B | 5.65 B | 5.63 B | 5.59 B | 5.88 B | 7.15 B | 6.34 B | 7.26 B | 6.75 B | 7.3 B | 6.54 B | 8.18 B | 8.95 B | 4.52 B | 3.07 B | 3.59 B | 2.29 B | 2.29 B | - | - |
Long Term Debt Current |
287 M | 258 M | 295 M | 299 M | 297 M | 390 M | 354 M | - | - | - | - | - | - | - | - | 417 M | 3 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 13.3 B | 13.8 B | 13.6 B | 14.1 B | 12.5 B | 12.3 B | 11.9 B | 6.36 B | 4.58 B | 4.94 B | - | - | - | - |
Total Current Liabilities |
67 B | 61.6 B | 52.4 B | 48 B | 48.5 B | 44.1 B | 42.6 B | 37.6 B | 36.7 B | 35.6 B | 35.1 B | 33.5 B | 29.5 B | 21.4 B | 21.7 B | 18.7 B | 17 B | 15.6 B | - | - |
Total Liabilities |
- | - | - | - | - | - | 55.9 B | 51.4 B | 50.3 B | 49.7 B | 47.6 B | 45.8 B | 41.4 B | 27.7 B | 26.3 B | 23.7 B | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | 63 M | 346 M | 919 M | 1.08 B | 1.24 B | 1.36 B | 1.42 B | 1.32 B | 1.22 B | 1.14 B | - | - |
Retained Earnings |
22.3 B | 17.9 B | 15 B | 12.3 B | 9.03 B | 8.2 B | 13 B | 12.4 B | 13 B | 13.2 B | 8.36 B | 12.7 B | 11.5 B | 10.4 B | 9.45 B | 8.25 B | 7.24 B | 6.1 B | - | - |
Total Assets |
82.3 B | 75.1 B | 67.4 B | 62.3 B | 63.3 B | 65 B | 61.2 B | 59.7 B | 60.4 B | 61 B | 56.6 B | 53.9 B | 51.8 B | 34.8 B | 33.1 B | 30.9 B | 28.2 B | 25.3 B | - | - |
Cash and Cash Equivalents |
3.98 B | 5.69 B | 4.58 B | 4.68 B | 3.53 B | 6.28 B | 4.02 B | 2.98 B | 2.67 B | 2.78 B | 4.05 B | 5.34 B | 4.19 B | 2.46 B | 3.15 B | 3.61 B | 3.73 B | 2.11 B | 1.36 B | 1.95 B |
Book Value |
82.3 B | 75.1 B | 67.4 B | 62.3 B | 63.3 B | 65 B | 5.31 B | 8.29 B | 10.1 B | 11.3 B | 9.01 B | 8.08 B | 10.3 B | 7.07 B | 6.83 B | 7.22 B | 28.2 B | 25.3 B | - | - |
Total Shareholders Equity |
-2.17 B | -2.07 B | -1.97 B | -1.86 B | -2.27 B | -21 M | 5.09 B | 8.09 B | 9.8 B | 11.1 B | 8.92 B | 8 B | 8.52 B | 7.07 B | 6.83 B | 7.22 B | 7.53 B | 6.19 B | 6.12 B | 6.27 B |
All numbers in USD currency
Quarterly Balance Sheet McKesson Corporation
| 2027-Q1 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 | 2009-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
9.73 B | 6.56 B | 7.76 B | 7.78 B | 6.56 B | 5.59 B | 7.78 B | 5.64 B | - | 5.74 B | 5.64 B | 5.66 B | - | 5.66 B | 5.59 B | - | - | - | 5.88 B | 5.52 B | 5.95 B | 6.41 B | 6.41 B | 6.47 B | 5.85 B | 6.4 B | 6.34 B | 6.73 B | 7.34 B | 7.38 B | 7.26 B | 7.62 B | 6.57 B | 6.59 B | 6.75 B | 7.51 B | 7.49 B | 7.42 B | 7.3 B | 5.97 B | 5.94 B | 5.94 B | 6.5 B | 7.72 B | 8.14 B | 8.14 B | 8.18 B | 8.98 B | 9.62 B | 10.1 B | 8.95 B | 4.52 B | 4.52 B | 4.52 B | 4.87 B | 3.97 B | 3.07 B | 3.07 B | 3.07 B | 3.58 B | 3.58 B | 3.58 B | 3.59 B | 2.3 B | 2.28 B | 2.28 B | 2.29 B | 2.29 B | 2.29 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 63 M | 68 M | 63 M | 279 M | 346 M | 402 M | 271 M | 820 M | 919 M | 999 M | 807 M | 939 M | 1.08 B | 1.23 B | 1 B | 1.12 B | 1.24 B | 1.29 B | 1.06 B | 1.16 B | 1.36 B | 1.43 B | 1.53 B | 1.32 B | 1.42 B | 1.47 B | 1.53 B | 1.29 B | 1.32 B | 1.36 B | 1.07 B | 1.16 B | 1.25 B | 994 M | 1.09 B |
Retained Earnings |
22.8 B | 20.7 B | 19.6 B | 18.6 B | 20.7 B | 16.8 B | 18.6 B | 15.8 B | - | 16 B | 15.8 B | 13.2 B | - | 13.2 B | 12.3 B | - | - | - | 9.03 B | 8.73 B | 8.81 B | 8.62 B | 8.2 B | 7.6 B | 13.9 B | 13.4 B | 13 B | 12.1 B | 12 B | 12.8 B | 12.4 B | 13.3 B | 13.4 B | 12.9 B | 13 B | 14.2 B | 13.4 B | 13.4 B | 13.2 B | 9.66 B | 9.09 B | 8.84 B | 8.36 B | 8 B | 13.8 B | 13.2 B | 12.7 B | 12.6 B | 12.2 B | 11.8 B | 11.5 B | 11.1 B | 11.1 B | 10.8 B | 10.4 B | 10.4 B | 10.1 B | 9.78 B | 9.45 B | 8.98 B | 8.73 B | 8.49 B | 8.25 B | 7.88 B | 7.77 B | 7.49 B | 6.92 B | 6.63 B | 6.36 B |
Total Assets |
88.3 B | 84.2 B | 84.2 B | 81.3 B | 84.2 B | 71.1 B | 81.3 B | 71.7 B | - | 72.4 B | 71.7 B | 64.1 B | - | 64.1 B | 62.3 B | - | - | - | 63.3 B | 63.7 B | 63.6 B | 62.9 B | 65 B | 61.8 B | 61.6 B | 57.7 B | 61.2 B | 60.9 B | 59 B | 61.7 B | 59.7 B | 61 B | 61.4 B | 61.3 B | 60.4 B | 64.2 B | 63.8 B | 61.8 B | 61 B | 57.9 B | 58.3 B | 57.9 B | 56.5 B | 55.1 B | 55.8 B | 55.9 B | 53.9 B | 55.1 B | 52.2 B | 53 B | 51.8 B | 36.5 B | 35.9 B | 35.5 B | 34.8 B | 33.4 B | 33 B | 31.7 B | 33.1 B | 33.2 B | 31.9 B | 31 B | 30.9 B | 30.4 B | 26.8 B | 27.4 B | 27.5 B | 26.6 B | 25.7 B |
Cash and Cash Equivalents |
5.16 B | 2.96 B | 4 B | 2.42 B | 2.96 B | 1.13 B | 2.42 B | 2.3 B | 1.13 B | 2.51 B | 2.3 B | 2.64 B | 2.52 B | 2.64 B | 4.68 B | - | - | 2.23 B | 3.53 B | 2.75 B | 2.15 B | 2.42 B | 6.28 B | 3.58 B | 3.58 B | 3.09 B | 2.61 B | 2.06 B | 2.06 B | 1.36 B | 1.95 B | 1.85 B | 2.12 B | 2.2 B | 2.67 B | 2.62 B | 2.56 B | 2.34 B | 2.78 B | 2.43 B | 5.46 B | 4.66 B | 4.05 B | 3.41 B | 5.36 B | 5.64 B | 5.34 B | 4.59 B | 3.8 B | 4.1 B | 4.19 B | 2.43 B | 2.96 B | 2.9 B | 2.46 B | 2.73 B | 2.83 B | 2.01 B | 3.15 B | 4.19 B | 3.94 B | 3.12 B | 3.61 B | 3.21 B | 3.05 B | 3.26 B | 3.43 B | 3.22 B | 2.64 B |
Book Value |
88.3 B | 84.2 B | 84.2 B | 81.3 B | 84.2 B | 71.1 B | 81.3 B | 71.7 B | - | 72.4 B | 71.7 B | 64.1 B | - | 64.1 B | 62.3 B | - | - | - | 63.3 B | 63.7 B | 63.6 B | 62.9 B | 65 B | 61.8 B | 61.6 B | 57.7 B | 61.2 B | 60.9 B | 59 B | 61.7 B | 59.7 B | 61 B | 61.4 B | 61.3 B | 60.4 B | 64.2 B | 63.8 B | 61.8 B | 61 B | 57.9 B | 58.3 B | 57.9 B | 56.5 B | 55.1 B | 55.8 B | 55.9 B | 53.9 B | 55.1 B | 52.2 B | 53 B | 51.8 B | 36.5 B | 35.9 B | 35.5 B | 34.8 B | 33.4 B | 33 B | 31.7 B | 33.1 B | 33.2 B | 31.9 B | 31 B | 30.9 B | 30.4 B | 26.8 B | 27.4 B | 27.5 B | 26.6 B | 25.7 B |
Total Shareholders Equity |
-4.24 B | -1.3 B | -1.74 B | -1.97 B | -1.3 B | -3.08 B | -1.97 B | -1.76 B | -2.7 B | -3.02 B | -1.38 B | -1.6 B | -1.46 B | -1.24 B | -1.86 B | - | - | -1.47 B | -2.27 B | -1.27 B | -571 M | -529 M | -21 M | -477 M | 5.89 B | 5.45 B | 5.09 B | 6.17 B | 6.48 B | 7.87 B | 8.09 B | 9.18 B | 9.33 B | 9.41 B | 9.8 B | 11.7 B | 11.1 B | 11.3 B | 11.1 B | 7.69 B | 9.45 B | 9.25 B | 8.92 B | 8.88 B | 8.79 B | 8.85 B | 8 B | 9.08 B | 8.93 B | 8.98 B | 8.52 B | 8.03 B | 7.99 B | 7.41 B | 7.07 B | 7.65 B | 7.72 B | 7.2 B | 6.83 B | 7.46 B | 7.12 B | 6.92 B | 7.22 B | 7.08 B | 6.82 B | 6.88 B | 7.12 B | 6.72 B | 6.27 B |
All numbers in USD currency
Balance Sheet is a fundamental financial report of McKesson Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Medical distribution
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
PPD, Inc.
PPD
|
- | 0.13 % | $ 16.6 B |  USA |
 |
Cardinal Health
CAH
|
$ 240.49 | 0.03 % | $ 56.8 B | USA |
 |
Henry Schein
HSIC
|
$ 88.86 | 0.52 % | $ 10.7 B | USA |
 |
Prestige Consumer Healthcare
PBH
|
$ 49.79 | 0.08 % | $ 2.41 B | USA |
 |
AmerisourceBergen Corporation
ABC
|
- | -0.23 % | $ 37.5 B | USA |
 |
Owens & Minor
OMI
|
- | - | $ 215 M | USA |
 |
Patterson Companies
PDCO
|
- | -0.87 % | $ 3 B | USA |